Authors:
Dazzi, C
Cariello, A
Rosti, G
Tienghi, A
Molino, A
Sabbatini, R
Aieta, M
Frassineti, GL
Vertogen, B
Giovanis, P
Marangolo, M
Citation: C. Dazzi et al., Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study, HAEMATOLOG, 86(5), 2001, pp. 523-529
Authors:
Sobrero, A
Guglielmi, A
Cirillo, M
Recaldin, E
Frassineti, GL
Aschele, C
Ravaioli, A
Testore, P
Caroti, C
Gallo, L
Pessi, MA
Cortesi, E
Turci, D
Grossi, F
Labianca, R
Citation: A. Sobrero et al., 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer, BR J CANC, 84(8), 2001, pp. 1023-1028
Authors:
Tesei, A
Ricotti, L
De Paola, F
Casini-Raggi, C
Barzanti, F
Frassineti, GL
Zoli, W
Citation: A. Tesei et al., Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study, J CHEMOTHER, 12(5), 2000, pp. 421-430
Authors:
Ricotti, L
Barzanti, F
Tesei, A
Amadori, D
Gasperi-Campani, A
Frassineti, GL
Zoli, W
Citation: L. Ricotti et al., Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established andprimary human breast cell cultures, ANN ONCOL, 11(5), 2000, pp. 587-594
Authors:
Sobrero, A
Zaniboni, A
Frassineti, GL
Aschele, C
Guglielmi, A
Giuliani, R
Ravaioli, A
Lanfranco, C
Caroti, C
Arnoldi, E
Barni, S
Gallo, L
Pessi, MA
Turci, D
Cortesi, E
Grossi, F
Frontini, L
Piazza, E
Bruzzi, P
Labianca, R
Citation: A. Sobrero et al., Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study, ANN ONCOL, 11(11), 2000, pp. 1413-1420
Authors:
Zoli, W
Ricotti, L
Barzanti, F
Dal Susino, M
Frassineti, GL
Milandri, C
Giunchi, DC
Amadori, D
Citation: W. Zoli et al., Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines, INT J CANC, 80(3), 1999, pp. 413-416
Authors:
Zoli, W
Ricotti, L
Dal Susino, N
Barzanti, F
Frassineti, GL
Folli, S
Tesei, A
Bacci, F
Amadori, D
Citation: W. Zoli et al., Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer, BR J CANC, 81(4), 1999, pp. 609-615